Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus
Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus
复制标题
DOI：
10.2165/00019053-200321110-00005
复制
发表时间：
2003-01-01
影响因子：
4.4
通讯作者：
Devine, ST
中科院分区：
文献类型：
--
作者：
Ramsdell, JW;Braunstein, SN;Devine, ST
目的：为了评估短期直接医疗成本和有效性与实现推荐的血糖目标使用常用的一线口服抗高血压药物在2型糖尿病材料和方法：一个基于文献的决策树模型，开发项目的患者人数达到糖化血红蛋白值的2型糖尿病，
Objective: To assess the short-term direct medical costs and effectiveness associated with achieving recommended glycaemic goals using commonly prescribed first-line oral antihyperglycaemic medications in type 2 diabetes mellitus.Materials and Methods: A literature-based, decision-tree model was developed to project the number of patients achieving glycosylated haemoglobin values of